A comprehensive evaluation of myocardial fibrosis in hypertrophic cardio myopathy with cardiacmagnetic resonance imaging: Linking genotype with fibrotic phenotype

European Heart Journal Cardiovascular Imaging

Volumn 15, Issue 10, 2014, Pages 1108-1116

  Ellims, Andris H ^a   Iles, Leah M ^a   Ling, Liang Han ^a   Chong, Belinda ^b   Macciocca, Ivan ^b   Slavin, Glenn S ^c   Hare, James L ^a   Kaye, David M ^a   Marasco, Silvana F ^a   McLean, Catriona A ^a   James, Paul A ^b   Du Sart, Desirée ^b   Taylor, Andrew J ^a  

^a ALFRED HOSPITAL   (Australia)

^b MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^c GE HEALTHCARE   (United States)

Author keywords

Genotyping; Hypertrophic cardio myopathy; Magnetic resonance imaging; Myocardial fibrosis; T1 mapping

Indexed keywords

COLLAGEN; GADOLINIUM; PENTETIC ACID; CONTRAST MEDIUM; GADOLINIUM PENTETATE;

ADULT; AGE; ARTICLE; BODY MASS; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL EVALUATION; CONCENTRATION (PARAMETERS); CONTRAST ENHANCEMENT; CONTROLLED STUDY; DYSPNEA; ECHOCARDIOGRAPHY; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; GENE MUTATION; GENOTYPE PHENOTYPE CORRELATION; HEALTH CARE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART MUSCLE FIBROSIS; HEART RATE; HEMATOCRIT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; NEXT GENERATION SEQUENCING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; RESTING HEART RATE; SYSTOLIC BLOOD PRESSURE; CASE CONTROL STUDY; DIAGNOSTIC USE; FIBROSIS; GENETICS; GENOTYPE; MIDDLE AGED; MUTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PHENOTYPE; PROCEDURES;

CARDIOMYOPATHY, HYPERTROPHIC; CASE-CONTROL STUDIES; CONTRAST MEDIA; ECHOCARDIOGRAPHY; FEMALE; FIBROSIS; GADOLINIUM DTPA; GENOTYPE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MUTATION; PHENOTYPE;

EID: 84912091124     PISSN: 20472404     EISSN: 20472412     Source Type: Journal    
DOI: 10.1093/ehjci/jeu077     Document Type: Article

References (28)

1. Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE et al. Task Force on Clinical Expert ConsensusDocuments. American College of C,Committee for Practice Guidelines. European Society of C. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardio myopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 2003;42: 1687-713.
2. Moon JC, Reed E, Sheppard MN, Elkington AG, Ho SY, BurkeMet al. The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardio myopathy. J Am Coll Cardiol 2004;43:2260-4.
3. O'Hanlon R, Grasso A, Roughton M, Moon JC, Clark S,Wage R et al. Prognostic significance of myocardial fibrosis in hypertrophic cardio myopathy. J Am Coll Cardiol 2010;56:867-74.
4. Varnava AM, Elliott PM, Sharma S, McKenna WJ, Davies MJ. Hypertrophic cardio myopathy: the interrelation of disarray, fibrosis, and small vessel disease. Heart 2000;84: 476-82.
5. SibleyCT, Noureldin RA, Gai N, Nacif MS, Liu S, Turkbey EB et al. T1 Mapping in cardio myopathy at cardiac MR: comparison with endomyocardial biopsy. Radiology 2012;265:724-32.
6. Iles L, Pfluger H, Phrommintikul A, Cherayath J, Aksit P, Gupta SN et al. Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. J Am Coll Cardiol 2008;52:1574-80.
7. Jarcho JA,McKennaW, Pare JA, Solomon SD, Holcombe RF, Dickie S et al. Mapping a gene for familial hypertrophic cardio myopathy to chromosome 14q1. N Engl J Med 1989;321:1372-8.
8. Ho CY. Genetics and clinical destiny: improving care in hypertrophic cardio myopathy. Circulation 2010;122:2430-40; discussion 2440.
9. Van Driest SL,OmmenSR, Tajik AJ, Gersh BJ, Ackerman MJ. Yield of genetic testing in hypertrophic cardio myopathy. Mayo Clin Proc 2005;80:739-44.
10. Olivotto I, Girolami F, Ackerman MJ, Nistri S, Bos JM, Zachara E et al. Myofilament protein gene mutation screening and outcome of patients with hypertrophic cardio myopathy. Mayo Clin Proc 2008;83:630-8.
11. Meder B, Haas J, Keller A, Heid C, Just S, Borries A et al. Targeted next-generation sequencing for the molecular genetic diagnostics of cardiomyopathies. Circ Cardiovasc Genet 2011;4:110-22.
12. Harrigan CJ, Peters DC, Gibson CM, Maron BJ, Manning WJ, Maron MS et al. Hypertrophic cardio myopathy: quantification of late gadolinium enhancement with contrast-enhanced cardiovascular MR imaging. Radiology 2011;258:128-33.
13. Maron MS. Clinical utility of cardiovascular magnetic resonance in hypertrophic cardio myopathy. J Cardiovasc Magn Reson 2012;14:13.
14. Saranathan M, Rochitte CE, Foo TK. Fast, three-dimensional free-breathing MR imaging of myocardial infarction: a feasibility study. Magn Reson Med 2004;51: 1055-60.
15. Gai N, Turkbey EB, Nazarian S, van der Geest RJ, Liu CY, Lima JA et al. T1 mapping of the gadolinium-enhanced myocardium: adjustment for factors affecting interpatient comparison. Magn Reson Med 2011;65:1407-15.
16. HadiAM, MouchaersKT, Schalij I, Grunberg K, Meijer GA, Vonk-NoordegraafAet al. Rapid quantification of myocardial fibrosis: a new macro-based automated analysis. Cell Oncol (Dordr) 2011;34:343-54.
17. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA et al. Chamber Quantification Writing G, American Society of Echocardiography's G, Standards C, European Association of E. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005;18:1440-63.
18. Sadedin SP, Pope B, Oshlack A. Bpipe: a tool for running and managing bioinformatics pipelines. Bioinformatics 2012;28:1525-6.
19. Wang K, Li M, Hakonarson H.ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res 2010;38:e164.
20. Ellims AH, Iles LM, Ling LH, Hare JL, Kaye DM, Taylor AJ. Diffuse myocardial fibrosis in hypertrophic cardio myopathy can be identified by cardiovascular magnetic resonance, and is associated with left ventricular diastolic dysfunction. J Cardiovasc Magn Reson 2012;14:76.
21. Ellims AH, Shaw JA, Stub D, Iles LM, Hare JL, Slavin GS et al. Diffuse myocardial fibrosis evaluated by post-contrast T1 mapping correlates with left ventricular stiffness. J Am Coll Cardiol 2014;63:1112-8.
22. Ho CY, Abbasi SA, Neilan TG, Shah RV, Chen Y, Heydari B et al. T1 measurements identify extracellular volume expansion in hypertrophic cardio myopathy sarcomere mutation carriers with and without left ventricular hypertrophy. Circ Cardiovasc Imaging 2013;6:415-22.
23. Gai ND, Stehning C, Nacif M, Bluemke DA. Modified Look-Locker T1 evaluation using Bloch simulations: human and phantom validation. Magn Reson Med 2013;69: 329-36.
24. Kellman P, Herzka DA, Hansen MS. Adiabatic inversion pulses for myocardial T1 mapping. Magn Reson Med 2013;41:1428-34.
25. Maron BJ, Yeates L, Semsarian C. Clinical challenges of genotype positive (±)-phenotype negative (2) family members in hypertrophic cardio myopathy. Am J Cardiol 2011;107:604-8.
26. Rowin EJ, Maron MS, Lesser JR, Maron BJ.CMRwith late gadolinium enhancement in genotype positive-phenotype negative hypertrophic cardio myopathy. JACC Cardiovasc Imaging 2012;5:119-22.
27. Flett AS, Hayward MP, Ashworth MT, Hansen MS, Taylor AM, Elliott PM et al. Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Circulation 2010;122: 138-44.
28. Moon JC, Messroghli DR, Kellman P, Piechnik SK, Robson MD, Ugander M et al. Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement. J Cardiovasc Magn Reson 2013; 15:92.